Trials / Sponsors / Mary Crowley Medical Research Center
Mary Crowley Medical Research Center
Academic / Other · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer | Phase 2 | 2016-06-03 |
| Withdrawn | Blood for Immune Response to Provenge® in HRPC Prostate Cancer | — | 2011-01-01 |
| Terminated | Phase I Trial of TGFB2-Antisense-GMCSF Gene Modified Autologous Tumor Cell (TAG) Vaccine for Advanced Cancer Carcinoma, Advanced Metastatic | Phase 1 | 2008-05-27 |